Population health

Performance Measurement for Health System Improvement: Experiences, Challenges and Prospects

Volumn , Issue , 2010, Pages 27-62

  Nolte, Ellen ^a   Bain, Chris ^b   McKee, Martin ^c,d  

^a RAND CORPORATION   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d EUROPEAN OBSERVATORY ON HEALTH SYSTEMS AND POLICIES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927043677     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511711800.003     Document Type: Chapter

References (106)

1. Albert, X., Bayo, A., Alfonso, J., Cortina, P., Corella D, (1996). ‘The effectiveness of health systems in influencing avoidable mortality: a study in Valencia, Spain, 1975-90.’ Journal of Epidemiology and Community Health, 50(3): 320-325.
2. Alvarez-Dardet, C., Ruiz M, (1993). ‘Thomas McKeown and Archibald Cochrane: a journey through the diffusion of their ideas.’ British Medical Journal, 306(6887): 1252-1255.
3. Arah, O., Westert, G., Hurst, J., Klazinga N, (2006). ‘A conceptual framework for the OECD Health Care Quality Indicators Project.’ International Journal for Quality in Health Care, 18 (Suppl. 1): 5-13.
4. Babazono, A., Hillman A, (1994). ‘A comparison of international health outcomes and health care spending.’ International Journal of Technology Assessment in Health Care, 10(3): 376-381.
5. Beaglehole, R (1986). ‘Medical management and the decline in mortality from coronary heart disease.’ British Medical Journal, 292(6512): 33-35.
6. Becker, N., Boyle P, (1997). ‘Decline in mortality from testicular cancer in West Germany after reunification.’ Lancet, 350(9079): 744.
7. Bennett, K., Kabir, Z., Unal, B., Shelley, E., Critchley, J., Perry, I., Feely, J., Capewell S, (2006). ‘Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000.’ Journal of Epidemiology and Community Health, 60(4): 322-327.
8. Berrino, F., De Angelis, R., Sant, M., Rosso, S., Bielska-Lasota, M., Coebergh, J., Santaquilani M,. & EUROCARE Working Group (2007). ‘Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study.’ Lancet Oncology, 8(9): 773-783.
9. Berrino, F., Gatta, G., Sant, M., Capocaccia R, (2001). ‘The EUROCARE study of survival of cancer patients in Europe: aims, current status, strengths and weaknesses.’ European Journal of Cancer, 37(6): 673-677.
10. Bots, M., Grobee D, (1996). ‘Decline of coronary heart disease mortality in the Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors.’ Journal of Cardiovascular Risk, 3(3): 271-276.
11. Brenner, G., Altenhofen, L., Bogumil, W., Heuer, J., Kerek-Bodden, H., Koch H, (2000). Gesundheitszustand und ambulante medizinische Versorgung der Bevolkerung in Deutschland im Ost-West-Vergleich. Cologne: Zentralinstitut fur die kassenarztliche Versorgung.
12. Britton, A., McKee M., Black, N., McPherson, K., Sanderson, C., Bain C, (1999). ‘Threats to applicability of randomised trials: exclusions and selective participation.’ Journal of Health Services Research and Policy, 4(2): 112-121.
13. Buck, D, Eastwood, A., Smith P, (1999). ‘Can we measure the social importance of health care?’ International Journal of Technology Assessment in Health Care, 15(1): 89-107.
14. Bunker, J (1995). ‘Medicine matters after all.’ Journal of the Royal College of Physicians, 29(2): 105-112.
15. Bunker, J., Frazier, H., Mosteller F, (1994). ‘Improving health: measuring effects of medical care.’ Milbank Memorial Fund Quarterly, 72(2): 225-258.
16. Butler, C., Currie, G., Anderson W, (2005). ‘Do differences in data reporting contribute to variation in lung cancer survival?’ Journal of the National Cancer Institute, 97(18): 1385.
17. Capewell, S., Beaglehole, R., Seddon, M., McMurray J, (2000). ‘Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993.’ Circulation, 102(13): 1511-1516.
18. Capewell, S., Morrison, C., McMurray J, (1999). ‘Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994.’ Heart, 81(4): 380-386.
19. Charlton J., Hartley, R., Silver, R., Holland W, (1983). ‘Geographical variation in mortality from conditions amenable to medical intervention in England and Wales.’ Lancet, 1(8326 Pt 1): 691-696.
20. Ciccolallo, L., Capocaccia, R., Coleman, M., Berrino, F., Coebergh, J., Damhuis, R., Faivre, J., Martinez-Garcia, C., Moller, H., Ponz de Leon, M., Launoy, G., Raverdy, N., Williams, E., Gatta G, (2005). ‘Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery.’ Gut, 54(2): 268-273.
21. Cochrane, A., Leger, A., Moore F, (1978). ‘Health service ‘input’ and mortality ‘output’ in developed countries.’ Journal of Epidemiology and Community Health, 32(3): 200-205.
22. Coleman, M., Babb, P., Damiecki, P., Grosclaude, P., Honjo, S., Jones, J., Knerer, G., Pitard, A., Quinn, M., Sloggett, A., De Stavola B, (1999). Cancer survival trends in England and Wales 1971-1995: deprivation and NHS region. London: The Stationary Office.
23. Colgrove, J (2002). ‘The McKeown thesis: a historical controversy and its enduring influence.’ American Journal of Public Health, 92(5): 725-729.
24. Collins, J (1982). ‘The contribution of medical measures to the decline of mortality from respiratory tuberculosis: an age-period-cohort model.’ Demography, 19(3): 409-427.
25. Cremieux, PY, Ouellette, P., Pilon C, (1999). ‘Health care spending as determinants of health outcomes.’ Health Economics, 8(7): 627-639.
26. De Leeuw, R., Cuttini, N., Nadai, M., Berbik, I., Hansen, G., Kucinskas, A., Lenoir, S., Levin, A., Persson, J., Rebagliato, M., Reid, M., Schroell, M., De Vonderweid, U. EURONIC Study Group (2000). ‘Treatment choices for extremely preterm infants: an international perspective.’ Journal of Pediatrics, 137(5): 608-616.
27. Elola, J., Daponte, A., Navarro V, (1995). ‘Health indicators and the organization of health care systems in western Europe.’ American Journal of Public Health, 85(10): 1397-1401.
28. Etches, V., Frank, J., Di Ruggiero, E., Manuel D, (2006). ‘Measuring population health: a review of indicators.’ Annual Review of Public Health, 27: 29-55.
29. European Commission (2007). The European Health Survey System. Brussels: European Commission (http://ec.europa.eu/health/ph_information/dissemination/reporting/ehss_en.htm).
30. Fairchild, A., Oppenheimer G, (1998). ‘Public health nihilism vs pragmatism: history, politics, and the control of tuberculosis.’ American Journal of Publtc Health, 88(7): 1105-1117.
31. Fenton, A., Field, D., Mason, E., Clarke M, (1992). ‘Attitudes to viability of preterm infants and their effect on figures for perinatal mortality.’ British Medical Journal, 300(6722): 434-436.
32. Ford, E., Ajani, U., Croft, J., Critchley, J., Labarthe, D., Kottke, T., Giles, W., Capewell S, (2007). ‘Explaining the decrease in US deaths from coronary disease, 1980-2000.’ New England Journal of Medicine, 356(23): 2388-2398.
33. Game, E (2001). ‘Perinatal mortality rates can no longer be used for comparing quality of perinatal health services between countries.’ Paediatric and Perinatal Epidemiology, 15(3): 315-316.
34. Garne, E., Berghold, A., Johnson, Z., Stoll C, (2001). ‘Different policies on prenatal screening programmes and induced abortions explain regional variations in infant mortality with congenital malformations.’ Fetal Diagnosis and Therapy, 16(3): 153-157.
35. Gatta, G., Capoccacia, R., Coleman, M., Ries, L., Hakulinen, T., Micheli, A., Sant, M., Verdecchia, A., Berrino F, (2000). ‘Toward a comparison of survival in American and European cancer patients.’ Cancer, 89(4): 893-900.
36. Gravelle, H., Blackhouse M, (1987). ‘International cross-section analysis of the determination of mortality.’ Social Science and Medicine, 25(5): 427-441.
37. Holland, W (1986). ‘The ‘avoidable death’ guide to Europe.’ Health Policy, 6(2): 115-117.
38. Holland, W (1988). European Community atlas of ‘avoidable death’. Oxford: Oxford University Press.
39. Hunink, M., Goldman, L., Tosteson, A., Mittelman, M., Goldman, P., Williams, L., Tsevat, J., Weinstein M, (1997). ‘The recent decline in mortality from coronary heart disease, 1980-1990.’ Journal of the American Medical Association, 277(7): 535-542.
40. Hussey, PS., Anderson, GF., Osborn, R., Feek, C., McLaughlin, V., Millar, J., Epstein A, (2004). ‘How does the quality of care compare in five countries?’ Health Affairs (Millwood), 23(3): 89-99.
41. Jack, R., Gulliford, M., Ferguson, J., Moller H, (2003). ‘Geographical inequalities in lung cancer management and survival in south east England: evidence of variation in access to oncology services?’ British Journal of Cancer, 88(7): 1025-1031.
42. Johansson, S (2005). ‘Commentary: the pitfalls of policy history. Writing the past to change the present.’ International Journal of Epidemiology, 34(3): 526-529.
43. Jougla, E., Papoz, L., Balkau, B., Maguin, P., Hatton F, (1992). ‘Death certificate coding practices related to diabetes in European countries - the ‘EURODIAB Subarea C’ study.’ International Journal of Epidemiology, 21(2): 343-351.
44. Jougla, E., Rossolin, F., Niyonsenga, A., Chappert, J-L., Johansson, L., Pavillon G, (2001). Comparability and quality improvement of the European causes of death statistics. Paris: INSERM.
45. Kelley, E., Hurst J, (2006). Health care quality indicators project. Conceptual framework paper. Paris: Organisation for Economic Co-operation and Development (OECD Health Working Papers No. 23).
46. Kelson, M., Farebrother M, (1987). ‘The effect of inaccuracies in death certification and coding practices in the European Economic Community (EEC) on international cancer mortality statistics.’ International Journal of Epidemiology, 16(3): 411-414.
47. Kessner, D., Kalk, C., Singer J, (1973). ‘Assessing health quality - the case for tracers.’ New England Journal of Medicine, 288(4): 189-194.
48. Kesteloot, H., Sans, S., Kromhaut D, (2006). ‘Dynamics of cardiovascular and all-cause mortality in western and eastern Europe between 1970 and 2000.’ European Heart Journal, 27(1): 107-113.
49. Kim, K., Moody P, (1992). ‘More resources better health? A cross-national perspective.’ Social Science and Medicine, 34(8): 837-842.
50. Kobayashi, S (2004). ‘What caused the decline in breast cancer mortality in the United Kingdom?’ Breast Cancer, 11(2): 156-159.
51. Koupilová, I., McKee, M., Holcik J, (1998). ‘Neonatal mortality in the Czech Republic during the transition.’ Health Policy, 46(1): 43-52.
52. Kricker, A (2002). Ovarian cancer in Australian women. Camperdown, NSW: National Breast Cancer Center.
53. Laatikainen, T., Critchley, J., Vartiainen, E., Salomaa, V., Ketonen, M., Capewell S, (2005). ‘Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997.’ American Journal of Epidemiology, 162(8): 764-773.
54. Lalonde, M (1974). A new perspective on the health of Canadians. Ottawa: Government of Canada.
55. Leon, D., Vagerö, D., Olausson P, (1992). ‘Social class differences in infant mortality in Sweden: comparison with England and Wales.’ British Medical Journal, 305(6855): 687-691.
56. Lopez, AD., Mathers, CD., Ezzati, M., Jamison, DT., Murray CJL, (2006). Global burden of disease and risk factors. New York: Oxford University Press and World Bank.
57. Mackenbach, J (1996). ‘The contribution of medical care to mortality decline: McKeown revisited.’ Journal of Clinical Epidemiology, 49(11): 1207-1213.
58. Mackenbach, J., Looman, C., Kunst, A., Habbema, J., van der Maas P, (1988). ‘Post-1950 mortality trends and medical care: gains in life expectancy due to declines in mortality from conditions amenable to medical intervention in the Netherlands.’ Social Science and Medicine, 27(9): 889-594.
59. Mackenbach, J., Van Duyne, W., Kelson M, (1987). ‘Certification and coding of two underlying causes of death in the Netherlands and other countries of the European Community.’ Journal of Epidemiology and Community Health, 41(2): 156-160.
60. Mariotto, A., Capocaccia, R., Verdecchia, A., Micheli, A., Feuer, E., Pickle, L., Clegg L, (2002). ‘Projecting SEER cancer survival rates to the US: an ecological regression approach.’ Cancer Causes Control, 13(2): 101-111.
61. Marques-Vidal, P., Ferrieres, J., Metzger, M., Cambou, J., Filipiak, B., Lowel, H., Keil U, (1997). ‘Trends in coronary heart disease morbidity and mortality and acute coronary care and case fatality from 1985-1989 in southern Germany and south-western France.’ European Heart Journal, 18(5): 816-821.
62. Mathers, C., Ma Fat, D., Inoue, M., Rao, C., Lopez A, (2005). ‘Counting the dead and what they died from: an assessment of the global status of cause of death data.’ Bulletin of the World Health Organization, 83(3): 171-77.
63. McColl, AJ., Gulliford MC, (1993). Population health outcome indicators for the NHS. A feasibility study. London: Faculty of Public Health Medicine and the Department of Public Health Medicine, United Medical and Dental Schools of Guy’s and St Thomas’ Hospitals.
64. McDowell, I., Spasoff, R., Kristjansson B, (2004). ‘On the classification of population health measurements.’ American Journal of Public Health, 94(3): 388-393.
65. McHaffie, H., Cuttini, M., Brolz-Voit, G., Randag, L., Mousty, R., Duguet, A., Wennergren, B., Benciolini P, (1999). ‘Withholding/withdrawing treatment from neonates: legislation and official guidelines across Europe.’ Journal of Medical Ethics, 25(6): 440-446.
66. McKee, M (1999). ‘For debate - Does health care save lives?’ Croatian Medical Journal, 40(2): 123-128.
67. McKee M, Shkolnikov, V. and Leon, D. (2001). ‘Alcohol is implicated in the fluctuations in cardiovascular disease in Russia since the 1980s.’ Annals of Epidemiology, 11(1): 1-6.
68. McKeown, T (1971). Medical issues in historical demography. In: Clarke, E (ed.). Modern methods in the history of medicine. London: Athlone Press.
69. McKeown, T. (1979). The role of medicine: dream, mirage or nemesis? Oxford: Blackwell.
70. McKinlay, J., McKinlay S, (1977). ‘The questionable contribution of medical measures to the decline of mortality in the United States in the twentieth century.’ Milbank Memorial Fund Quarterly, 55(3): 405-428.
71. Murray, C., Salomon, J., Mathers C, (2000). ‘A critical examination of summary measures of population health.’ Bulletin of the World Health Organization, 78(8): 981-994.
72. Murray, C., Salomon, J., Mathers, C., Lopez A, (eds.) (2002). Summary measures of population health. Concepts, ethics, measurement and applications. Geneva: World Health Organization.
73. Nixon, J., Ulmann P,. (2006). ‘The relationship between health care expenditure and health outcomes. Evidence and caveats for a causal link. European Journal of Health Economics, 7(1): 7-18.
74. Nolte, E., Bain, C., McKee M, (2006). ‘Chronic diseases as tracer conditions in international benchmarking of health systems: the example of diabetes.’ Diabetes Care, 29: 1007-1011.
75. Nolte, E., Brand, A., Koupilova, I., McKee M, (2000). ‘Neonatal and postneonatal mortality in Germany since unification.’ Journal of Epidemiology and Community Health, 54(2): 84-90.
76. Nolte, E., McKee M, (2004). Does healthcare save lives? Avoidable mortality revisited. London: The Nuffield Trust.
77. Nolte, E., McKee M, (2008). ‘Measuring the health of nations: updating an earlier analysis.’ Health Affairs, 27(1): 58
78. Nolte, E., McKee, M., Wait S, (2005). Describing and evaluating health systems. In: Bowling, A. Ebrahim, S (eds.) Handbook of health research methods: investigation, measurement and analysis. Maidenhead: Open University Press.
79. Nolte, E., Scholz, R., Shkolnikov, V., McKee M, (2002). ‘The contribution of medical care to changing life expectancy in Germany and Poland.’ Social Science and Medicine, 55(11): 1907-1923.
80. OECD (2007). OECD health data 2007. Paris: Organisation for Economic Co-operation and Development.
81. Or, Z (2000). ‘Determinants of health outcomes in industrialised countries: a pooled, cross-country, time-series analysis.’ OECD Economic Studies, 30: 53-77.
82. Or, Z (2001). Exploring the effects of health care on mortality across OECD countries. Paris: Organisation for Economic Co-operation and Development (Labour Market and Social Policy Occasional Paper No. 46).
83. Pennington, C (1979). ‘Mortality and medical care in nineteenth-century Glasgow.’ Medical History, 23(4): 442-450.
84. Reidpath, D (2005). ‘Population health. More than the sum of the parts?’ Journal of Epidemiology and Community Health, 59(10): 877-880.
85. Richardus, J., Graafmans, W., Verloove-Vanhorick, S., Mackenbach J, (1998). ‘The perinatal mortality rate as an indicator of quality of care in international comparisons.’ Medical Care, 36(1): 54-66.
86. Richardus, J., Graafmans, W., Verloove-Vanhorick, S., Mackenbach J,. EuroNatal International Audit Panel, EuroNatal Working Group (2003). ‘Differences in perinatal mortality and suboptimal care between 10 European regions: results of an international audit.’ British Journal of Obstetrics and Gynaecology, 110(2): 97-105.
87. Rutstein, D., Berenberg, W., Chalmers, T., Child, C., Fishman, A., Perrin E, (1976). ‘Measuring the quality of medical care. A clinical method.’ New England Journal of Medicine, 294(11): 582-588.
88. Ruzicka, L., Lopez A, (1990). ‘The use of cause-of-death statistics for health situation assessment: national and international experiences.’ World Health Statistics Quarterly, 43(4): 249-258.
89. Sant, M., Allemani, C., Berrino, F., Coleman, M., Aareleid, T., Chaplain, G., Coebergh, J., Colonna, M., Crosignani, P., Danzon, A., Federico, M., Gafà, L., Grosclaude, P., Hédelin, G., Macè-Lesech, J., Garcia, C., Møller, H., Paci, E., Raverdy, N., Tretarre, B., Williams E,. European Concerted Action on Survival and Care of Cancer Patients (EUROCARE) Working Group (2004). ‘Breast carcinoma survival in Europe and the United States.’ Cancer, 100(4): 715-722.
90. Schneyder, S., Landefeld, J., Sandiffer F, (1981). ‘Biomedical research and illness: 1900-1979.’ Milbank Memorial Fund Quarterly, 59(1): 44-58.
91. Scioscia, M., Vimercati, A., Maiorano, A., Depalo, R., Selvaggi L, (2007). ‘A critical analysis on Italian perinatal mortality in a 50-year span.’ European Journal of Obstetrics, Gynecology, and Reproductive Biology, 130(1): 60-65.
92. Szreter, S (1988). ‘The importance of social interventions in Britain’s mortality decline.’ Social History of Medicine, 1(1): 1-37.
93. Tunstall-Pedoe, H., Kuulasmaa, K., Mähönen, M., Tolonen, H., Ruokokoski, E., Amouyel P, (1999). ‘Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations.’ Lancet, 353(9164): 1547-1557.
94. Tunstall-Pedoe, H., Vanuzzo, D., Hobbs, M., Mahonen, M., Cepatis, Z., Kuulasmaa, K., Keil U, (2000). ‘Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA project populations.’ Lancet, 355(9205): 688-700.
95. Unal, B., Critchley, J., Capewell S, (2007). ‘Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000.’ Circulation, 109(9): 1101-1107.
96. Uuskula, M., Lamp, K., Vali M, (1998). ‘An age-related difference in the ratio of sudden coronary death over acute myocardial infarction in Estonian males.’ Journal of Clinical Epidemiology, 51(7): 577-580.
97. Van derPal-de Bruin, K., Graafmans, W., Biermans, M., Richardus, J., Zijlstra, A., Reefhuis, J., Mackenbach, J., Verloove-Vanhorick S, (2002). ‘The influence of prenatal screening and termination of pregnancy on perinatal mortality rates.’ Prenatal Diagnosis, 22(11): 966-972.
98. Van der Zee, J., Kroneman M, (2007). ‘Bismarck or Beveridge: a beauty contest between dinosaurs.’ BMC Health Services Research, 7(1): 94.
99. Verdecchia, A., Francisci, S., Brenner, H., Gatta, G., Micheli, A., Mangone, L., Kunkler I,. EUROCARE-4 Working Group (2007). ‘Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.’ Lancet Oncology, 8(9): 784-796.
100. WHO (2000). The world health report 2000. Health systems: improving performance. Geneva: World Health Organization.
101. WHO Regional Office for Europe (2003). Strategic plan for measles and congenital rubella infection in the European region of WHO. Copenhagen: WHO Regional Office for Europe.
102. WHO Regional Office for Europe (2007). European Health for All database [offline database]. Copenhagen: WHO Regional Office for Europe (January update).
103. Wiesner, G., Grimm, J., Bittner E, (1999). ‘Zum Herzinfarktgeschehen in der Bundesrepublik Deutschland: Prävalenz, Inzidenz, Trend, Ost-West- Vergleich.’ Gesundheitswesen, 61(Suppl. 2): 72-78.
104. Wilson, L (2005). ‘Commentary: medicine, population, and tuberculosis.’ International Journal of Epidemiology, 34(3): 521-524.
105. Wright, J., Weinstein M, (1998). ‘Gains in life expectancy from medical interventions - standardizing data on outcomes.’ New England Journal of Medicine, 339(6): 380-386.
106. Zatonski, W., McMichael, A., Powles J, (1998). ‘Ecological study of reasons for the sharp decline in mortality from ischaemic heart disease in Poland since 1991.’ British Medical Journal, 316(7137): 1047-1051.